Sputnik V vaccine 95% effective: Russia

Vastavam web: Amid the race to develop and distribute a potential coronavirus vaccine, Russia on Tuesday announced that its Sputnik V covid-19 vaccine is 95% effective and will be charged less than rival vaccines as Moscow aims to produce more than 1 billion doses at home and abroad next year.Cost of Russia’s two-shot Sputnik V vaccine will be less than $20 per person for international markets with each shot costing less than $10. informed Russian sovereign wealth fund. Earlier this month, developers of Sputnik V, RDIF and Gamaleya Institute, announced interim data from a large trial suggests the shot appears to be 92% effective.

According to an official statement, Sputnik V vaccination will be free of charge for Russian citizens. Customers who recently submitted requests will get first batches of the vaccine starting from March 2021. On August 11, the Sputnik V vaccine was registered by the Ministry of Health of Russia and became the world’s first registered vaccine against COVID-19 based on the human adenoviral vector platform. On Monday, British-Swedish drugmaker AstraZeneca said its covid vaccine for the novel coronavirus, developed along with the University of Oxford, could be around 90% effective under one dosing regimen.

The US-based pharma giant will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag (WamS). Similarly, on November 18, Pfizer-BioNTech developed vaccine candidate’s final results from the late-stage trial of its coronavirus vaccine was found to be 95% effective and had no serious side effects on older people. Meanwhile, back in India, Dr Reddy’s Laboratories will soon start combined phase 2 and 3 clinical trials of the Russian COVID-19 vaccine Sputnik V in India.